METASTATIC SOLID TUMORS
Clinical trials for METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive seeds may boost cancer control in patients with multiple metastases
Disease control Not yet recruitingThis study is for people with 6 to 10 metastatic tumors who cannot have surgery or other local treatments. It tests whether adding tiny radioactive seeds (iodine-125) placed directly into tumors, along with standard drug therapy, can slow cancer growth better than drugs alone. Th…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Li Min • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hope for rare cancers: precision trial launches in china
Disease control Not yet recruitingThis study tests new anti-cancer drugs and technologies in 600 people with rare advanced solid tumors that have stopped responding to standard treatments. Participants receive therapies matched to their tumor's unique genetic profile. The goal is to see if these treatments are sa…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New drug cocktail aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis study tests a new drug combination (QLC5513 plus QL1706, with or without platinum chemotherapy) in people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New drug QLS5308 enters early human testing for advanced cancers
Disease control Not yet recruitingThis early-phase study tests a new drug called QLS5308 in about 192 people with advanced solid tumors that have spread and cannot be removed by surgery or radiation. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. This is a firs…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Radioactive drug trial targets painful bone metastases in advanced cancer
Disease control Not yet recruitingThis study is testing a new radioactive drug called BPR-6023021 for people with advanced solid tumors that have spread to the bones. The main goals are to find a safe dose and see how well the drug works to control the cancer in the bones. The trial is for adults whose cancer has…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 13, 2026 20:23 UTC